[Beta interferon therapy of HPV infections of the female genital tract].
The aim of the study was to evaluate the incidence of cervical and vaginal lesions due to Papilloma virus before and after beta-interferon therapy. Clinical symptoms and the therapeutic approach are described, whereas drug efficacy was assessed on a long-term basis. The study of 19 cases, brought to the Author's attention over an eight-year period (1984-91) confirms previously published reports: the use of interferon shows a good level of tolerability without complications and undeniable efficacy following surgical treatment.
Basso
P
P
Università degli Studi di Verona, Divisione di Ostetricia-Ginecologia, Ospedale di Cavalese Trento.
Verdi
F
F
D000328:Adult; D003218:Condylomata Acuminata / Q000188:drug therapy / Q000382:microbiology* / Q000601:surgery; D005260:Female; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D008875:Middle Aged; D027383:Papillomaviridae / Q000187:drug effects; D014412:Tumor Virus Infections / Q000188:drug therapy; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy* / Q000382:microbiology / Q000601:surgery
D016899:Interferon-beta
Trattamento con beta-interferone nelle infezioni da HPV dell'apparato genitale femminile.